FFCP PHASE1:Mm9::chr12:45501817..45501821,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=37|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:45501817..45501821,+|id=chr12:45501817..45501821,+|ontology_enrichment_celltype=CL:0000325!1.33e-15!2;CL:0000217!1.33e-15!2;CL:0000328!1.33e-15!2;CL:0002573!1.33e-15!2;CL:0002376!1.33e-15!2;CL:0000218!1.33e-15!2;CL:0000692!1.33e-15!2;CL:0002377!1.33e-15!2;CL:0002375!1.33e-15!2;CL:0000215!7.15e-11!3;CL:0000630!7.15e-11!3|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001911!1.68e-58!2;UBERON:0000076!1.68e-58!2;UBERON:0005333!1.68e-58!2;UBERON:0008425!1.68e-58!2;UBERON:0005311!1.68e-58!2;UBERON:0003100!1.07e-11!11;UBERON:0005085!4.49e-10!13;UBERON:0005153!5.82e-08!17|ontology_enrichment_uberon_v019_2=UBERON:0001911,1.87e-86,2;UBERON:0000076,1.87e-86,2;UBERON:0005333,1.87e-86,2;UBERON:0008425,1.87e-86,2;UBERON:0005311,1.87e-86,2;UBERON:0003100,5.67e-17,11;UBERON:0005085,1.42e-14,13;UBERON:0005153,1.86e-11,17;UBERON:0005157,6.23e-10,20;UBERON:0002365,3.41e-08,25;UBERON:0002330,3.41e-08,25|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0755715601067855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.37646409528554,1.65562047782839,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:45501817..45501821,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=37 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:45501817..45501821,+ | |||
|description=CAGE_peak_at_chr12:45501817..45501821,+ | |||
|id=chr12:45501817..45501821,+ | |||
|ontology_enrichment_celltype=CL:0000325!1.33e-15!2;CL:0000217!1.33e-15!2;CL:0000328!1.33e-15!2;CL:0002573!1.33e-15!2;CL:0002376!1.33e-15!2;CL:0000218!1.33e-15!2;CL:0000692!1.33e-15!2;CL:0002377!1.33e-15!2;CL:0002375!1.33e-15!2;CL:0000215!7.15e-11!3;CL:0000630!7.15e-11!3 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001911!1.68e-58!2;UBERON:0000076!1.68e-58!2;UBERON:0005333!1.68e-58!2;UBERON:0008425!1.68e-58!2;UBERON:0005311!1.68e-58!2;UBERON:0003100!1.07e-11!11;UBERON:0005085!4.49e-10!13;UBERON:0005153!5.82e-08!17 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001911,1.87e-86,2;UBERON:0000076,1.87e-86,2;UBERON:0005333,1.87e-86,2;UBERON:0008425,1.87e-86,2;UBERON:0005311,1.87e-86,2;UBERON:0003100,5.67e-17,11;UBERON:0005085,1.42e-14,13;UBERON:0005153,1.86e-11,17;UBERON:0005157,6.23e-10,20;UBERON:0002365,3.41e-08,25;UBERON:0002330,3.41e-08,25 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0755715601067855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.37646409528554,1.65562047782839,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:45501817..45501821,+ | |||
}} |
Latest revision as of 01:29, 5 August 2015
Short description: | p@chr12:45501817..45501821, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:45501817..45501821, + |
Coexpression cluster: | MCL_coexpression_mm9:37 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mammary gland | 1.87e-86 | 2 |
external ectoderm | 1.87e-86 | 2 |
mammary bud | 1.87e-86 | 2 |
mammary ridge | 1.87e-86 | 2 |
mammary placode | 1.87e-86 | 2 |
female organism | 5.67e-17 | 11 |
ectodermal placode | 1.42e-14 | 13 |
epithelial bud | 1.86e-11 | 17 |
epithelial fold | 6.23e-10 | 20 |
exocrine gland | 3.41e-08 | 25 |
exocrine system | 3.41e-08 | 25 |